Cited by 117Prenatal Screening and DiagnosticsAssisted Reproductive Technology and Twin PregnancyMedical and Health Sciences Research

Preimplantation genetic diagnosis at 20 years

Simpson, Joe Leigh·2010·Prenatal Diagnosis

Abstract

First reported in 1990, PGD has evolved into a complementary form of prenatal diagnosis offering novel indications. DNA for PGD can be recovered with equal safety and facility from polar bodies I and II, blastomere (8 cell embryo) and trophectoderm (5-6 day blastocyst). Diagnostic accuracy is very high (>99%) for both chromosomal abnormalities and single gene disorders. Traditional application of FISH with chromosome specific probes for detecting aneuploidy and translocations may be replaced or complemented by array comparative genome hybridization (array CGH); biopsied embryos can now be cryopreserved (vitrification) while analysis proceeds in orderly fashion. PGD has been accomplished for over 200 different single gene disorders. Novel indications for PGD not readily applicable by traditional prenatal genetic diagnosis include avoiding clinical pregnancy termination, performing preconceptional diagnosis (polar body I), obtaining prenatal diagnosis without disclosure of prenatal genotype (nondisclosure), diagnosing adult-onset disorders particularly cancer, and identifying HLA compatible embryos suitable for recovering umbilical cord blood stem cells.

Integrity signals

Registry

Crossref · 10.1002/pd.2552

Cites

130 of 130 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

  • Efforts have been made to develop diagnostic techniques using cell free fetal DNA in maternal blood samples, but these are not yet routinely available.

    “In order to minimize the exposure to Dex, efforts have been made to develop diagnostic techniques using cell free fetal DNA in maternal blood samples, but these are not yet routinely available (see section IV.D)(325).”
  • Targeted massive parallel sequencing of cell-free fetal DNA in maternal plasma can identify SNPs flanking CYP21A2 that are specific for the mother, father, and proband, thus constructing haplotype blocks to determine the maternal and paternal alleles inherited by the fetus.

    “Instead, targeted massive parallel sequencing of cell-free fetal DNA in maternal plasma can identify SNPs flanking CYP21A2 that are specific for the mother, father, and proband (previous child), thus constructing haplotype blocks to determine the maternal and paternal alleles inherited by the fetus (325).”

Cites

Flagged first, then by citations

Cited by

Sorted by citations

Authors
Simpson, J. L.
Affiliations
Florida International University (US)
Corresponding author
Simpson, Joe Leigh
Venue
Prenatal Diagnosis
Publisher
Wiley
Published
2010-06-22
Volume
30
Issue
7
Pages
682-695
ISSN
  • 0197-3851 (ISSN-L)
  • 1097-0223
OpenAlex
W1981520497
Cited by
117
References
130
Citations by year
2024: 2 · 2023: 6 · 2022: 2 · 2021: 3 · 2020: 4 · 2019: 5 · 2018: 7 · 2017: 6 · 2016: 10 · 2015: 6 · 2014: 9 · 2013: 19 · 2012: 22
FWCI
2.69
Type
journal article
Language
en
Open access
closed
Locations
  • Prenatal Diagnosis (publishedVersion)
  • PubMed (publishedVersion)
Topics
  • Health Sciences › Medicine › Pediatrics, Perinatology and Child Health › Prenatal Screening and Diagnostics
  • Health Sciences › Medicine › Pediatrics, Perinatology and Child Health › Assisted Reproductive Technology and Twin Pregnancy
  • Health Sciences › Medicine › Public Health, Environmental and Occupational Health › Medical and Health Sciences Research
Keywords
preimplantation genetic diagnosis, blastomere biopsy, trophectoderm biopsy, aneuploidy detection, translocation detection, embryo cryopreservation, monogenic disorders, HLA matching, umbilical cord blood stem cells
MeSH terms
Blastomeres, Chromosome Aberrations, DNA, Female, Humans, Pregnancy, In Situ Hybridization, Fluorescence, Preimplantation Diagnosis

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review